Vincogen corporation (www.vincogen.com) is the Biotechnology - Artificial Intelligence company and has developed VincoAI, a collection of generative AI models. VincoAI is the first proof-of-concept generative AI to accurately predict amino acid sequences based on high-quality protein data. Vincogen is focusing on niche markets, an AI based personalized/precision medicine, with superior VincoAI platforms to provide the needs of human beings. Significantly, the company's novel biotechnology is beyond the development stage. VincoAI Our technology, VincoAI, is a Large Language Model not trained on language -- but on amino acids binding pairs. A collection of generative AI models. It is the first Proof-of-Concept peptide-binding Generative AI platform that produces novel peptide sequences (Vinco Peptides) that can bind onto the active or binding sites of targeted AMR proteins.